Anacetrapib

SI-5698

Anacetrapib, >98% (HPLC)

CAS No. : [875446-37-0]

MDL No. : MFCD16294903

Synonyms : MK-0859; EAI045

IUPAC Name : (4S,5R)-5-(3,5-Bis(trifluoromethyl)phenyl)-3-((4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methyl)-4-methyloxazolidin-2-one

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
250MG	Request A Quote		In Stock	Estimated to ship on 20 September 2026
1G	Request A Quote		In Stock	Estimated to ship on 20 September 2026
5G	Request A Quote		In Stock	Estimated to ship on 20 September 2026
10G	Request A Quote		In Stock	Estimated to ship on 20 September 2026

Applications : Anacetrapib is a potent CETP inhibitor, It is being developed to treat elevated cholesterol levels in an effort prevent cardiovascular disease. In 2017 its development was abandoned by Merck.

References : Niesor E. J. et al.: J. Lipid Res., 51(12), 3443-3454, 2010; Dong B. et al.: Atherosclerosis 235(2), 449-62, 2014; Tan E. Y. et al.: Drug Metab Dispos. 38(3), 459-473, 2010.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.